Track topics on Twitter Track topics that are important to you
Pfizer Inc. (PFE) announced positive top-line results of a Phase 3 study examining the use of Lyrica or pregabalin Oral Solution CV as adjunctive therapy for partial onset seizures in pediatric epilepsy patients aged one month to less than four years.
Original Article: Pfizer: Lyrica Oral Solution CV Phase 3 Trial Meets Primary EndpointNEXT ARTICLE
Pfizer is a global pharmaceutical company, the largest in world based on annual sales. In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...